Catalyst Biosciences Stock News

Uber Technologies, Inc. (NYSE:UBER) with the stream of 1.53% also noticed, India Catalyst Biosciences, Inc. (NASDAQ:CBIO) encountered a rapid change of -2.93% in the last hour of Wednesdays trading session. The post Active Stock Evaluation: Uber Technologies, Inc. (NYSE:UBER), Catalyst Biosciences, Inc. (NASDAQ:CBIO) appeared first on Stocks Equity .

Catalyst Biosciences Inc (CBIO) shares closed today at 0.8% above its 52 week low of $1.24, giving the company a market cap of $39M. The stock is currently down 80.2% year-to-date, down 78.4% over the past 12 months, and down 89.5% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%. Trading Activity Trading volume this week was 19.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 720.7% The company's stock price performance over the past 12 months lags the peer average by 588.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that members of its executive management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, being held November 29-December

Catalyst Biosciences Inc. (NASDAQ:CBIO) price on Wednesday, November 17, fall -6.49% below its previous days close as a downside momentum from buyers pushed the stocks value to $1.44. A look at the stocks price movement, the close in the last trading session was $1.54, moving within a range at $1.42 and $1.57. The beta value What Does 2021 Hold For Catalyst Biosciences Inc. (NASDAQ:CBIO)? Read More »

Catalyst Biosciences, Inc. (CBIO) with the stream of -2.40% also noticed, India Abeona Therapeutics Inc. (ABEO) encountered a rapid change of -1.77% in the last hour of Tuesdays trading session. The post Bright Stock Buzz: Catalyst Biosciences, Inc. (NASDAQ:CBIO), Abeona Therapeutics Inc. (NASDAQ:ABEO) appeared first on Stocks Equity .

In the last trading session, 1.39 million Catalyst Biosciences Inc. (NASDAQ:CBIO) shares changed hands as the companys beta touched 1.78. With the companys per share price at $1.67 changed hands at -$0.04 or -2.34% during last session, the market valuation stood at $90.05M. CBIOs last price was a discount, traded about -352.1% off its 52-week Catalyst Biosciences Inc. (NASDAQ: CBIO) : Investors Should Not Dump CBIO Stock In 2021 Read More »

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that its chief financial officer, Clinton Musil, has resigned for personal rea

SOUTH SAN FRANCISCO, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Disea

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that a fireside chat including members of its executive management team will b

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced its operating and financial results for the second quarter ended June 30, 2021,

Launching the ConFIrm study to identify patients with Complement Factor I deficiencies Launching the ConFIrm study to identify patients with Complement Factor I deficiencies

SOUTH SAN FRANCISCO, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today presented four posters at the International Society for Thrombosis and Haemostasis (ISTH)

SOUTH SAN FRANCISCO, Calif., July 06, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced four poster presentations on marzaptacog alfa (activated) (MarzAA) and dalcinan

Which penny stocks are investors watching as June comes to an end? The post 8 Penny Stocks to Watch Right Now As June Comes to an End appeared first on Penny Stocks to Buy, Picks, News and Information